[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![FLOATRAIDER Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::4873480024.png) FloatRaider [@FLOATRAIDER](/creator/twitter/FLOATRAIDER) on x XX followers
Created: 2025-07-14 14:15:34 UTC

GLMD has been consolidating between $1.95–$1.99 = a textbook pause ahead of the July XX definitive licensing agreement. With oral sublingual semaglutide targeting emerging GLP‑1 markets, brace for a potential breakout. #biotech #stocks $BGLC $DWAC $DBGI $SNDL $FWBI $GNS  $JAGX


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944762699201618021/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$jagx](/topic/$jagx)
[$fwbi](/topic/$fwbi)
[$sndl](/topic/$sndl)
[$dbgi](/topic/$dbgi)
[$dwac](/topic/$dwac)
[$bglc](/topic/$bglc)
[$gns](/topic/$gns)

[Post Link](https://x.com/FLOATRAIDER/status/1944762699201618021)